Home Your basket
• Hearing aid : practical a...
   Price 10.50 €
• Different clinical approa...
   Price 5.50 €
• Otomycosis: Clinical and ...
   Price 5.50 €
• Efficacy and safety of mo...
   Price 10.50 €
• Evaluation of the presenc...
   Price 12.50 €
• Synovial sarcoma of the h...
   Price 5.50 €
• What we don’t know about ...
   Price 12.50 €
• Time-intensity trade of b...
   Price 10.50 €
• Cervical and pharyngeal i...
   Price 5.50 €
• Glomangioma or "glomic tu...
   Price 5.50 €
• Adenoid cystic carcinoma ...
   Price 5.50 €
• Early ENT manifestations ...
   Price 10.50 €
• Vertigo: progress and pra...
   Price 8.50 €
• Correlation between the r...
   Price 12.50 €
• Extramuscular soft tissue...
   Price 8.50 €
• Vertical extended hemi cr...
   Price 5.50 €
• Evaluation of the efficie...
   Price 10.50 €
• Anosmia following superio...
   Price 5.50 €
• Kikuchi-Fujimoto’s diseas...
   Price 5.50 €
• Vocal forcing and posture...
   Price 10.50 €
• Ectopic ossification in t...
   Price 5.50 €
• Diagnosis and treatment o...
   Price 8.50 €
• Guidelines for the clinic...
   Price 12.00 €
• Free novascularized bone ...
   Price 15.00 €
• Interest of the chest CT ...
   Price 10.50 €
• Salivary gland choristoma...
   Price 5.50 €
• Laryngeal cryptococcosis ...
   Price 8.50 €
• The input of autogenous g...
   Price 10.50 €
• Revascularized free scapu...
   Price 10.50 €
• Medicamentous toxic heari...
   Price 5.50 €
• Singular neurectomy for r...
   Price 12.00 €
• Chyle leak after cervical...
   Price 15.00 €
• Ambulatory stapedectomy: ...
   Price 8.50 €
• Efficacy of nasal irrigat...
   Price 15.00 €
• Otologic surgery in HIV-i...
   Price 8.50 €
• Carcinogenesis of the eth...
   Price 10.50 €
• Going from the tube feedi...
   Price 8.50 €
• Esthesioneuroblastoma in ...
   Price 8.00 €

Total Order 345.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

CERVICO-FACIAL CARCINOLOGY

Sarcomatoid carcinomas of the upper airways


Authors : Oueslati Z, Ben Miled M, Hammoud M, Touati S, Lachkham A, Gamoudi A, Mokni N, El Benna F, Boussen H, El May A, Ladgham A. (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:191-195.

Article published in french
Downloadable PDF document french



Summary : Introduction: The sarcomatoid carcinoma of the superior aerodigestive tracts is a rare malignant tumour, which presents diagnostic and therapeutic challenges. Material and method: We report 11 cases of spindle cell carcinomas of the upper airways. Results: Sex-ratio was 10:1 and the mean age was 57.3 years (30 - 75 years). Nine patients were smokers and 4 presented with a history of radiation exposure. Tumoral locations were as follows: larynx: 6, hypopharynx: 1, oropharynx: 1, nasopharynx: 1, oral cavity: 2. Histological diagnosis in 3 cases required the use of immunohistochemical studies. Four patients were first seen at an advanced stage. This left 9 patients and among them 7 received a curative treatment: 5 by surgery alone, 1 by surgery and radiotherapy, 1 by radiotherapy, 1 by chemo-radiotherapy for the nasopharyngeal lesion and 1 by chemotherapy alone. Two patients died from their disease before treatment. With an average delay of 15.4 months, the rates of global survival and disease-free were 5/9 and 4/9 respectively. Conclusion: The sarcomatoid carcinoma of the upper airways is rare, but not unusual. Its diagnosis benefits from progresses in immunohistochemistry, but also from advances in the field of molecular biology. Its treatment and natural evolution remain controversial.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE